Clinical Trial: IV Hydrogen Nanobubbles for Cardiac Function and QoL

U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07085637) titled 'IV Hydrogen Nanobubbles for Cardiac Function and QoL' on June 02.

Brief Summary: The goal of this clinical trial is to learn if intravenous hydrogen nanobubbles (HNBs) improve cardiovascular function and quality of life in adults. It will also explore the dose-dependent effects of HNBs when given through IV infusion.

The main questions it aims to answer are:

1. Do HNBs improve heart function and blood vessel health (e.g., blood pressure, ejection fraction, flow-mediated dilation)?

2. How do different doses of HNBs affect quality of life as measured by the SF-36 questionnaire?

3. Are there any safety or tolerability concerns with...